Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington’s Disease

Abstract

Huntington’s disease (HD) is a rare, hereditary, and progressive neurodegenerative disease, characterized by involuntary choreatic movements with cognitive and behavioral disturbances. In order to mitigate impairments in motor function, physical exercise was integrated in HD rehabilitative interventions, showing to be a powerful tool to ameliorate the quality of life of HD-affected patients. This review aims to describe the effects of physical exercise on HD-related skeletal muscle disorders in both murine and human models. We performed a literature search using PubMed, Scopus, and Web of Science databases on the role of physical activity in mouse models of HD and human patients. Fifteen publications fulfilled the criteria and were included in the review. Studies performed on mouse models showed a controversial role played by exercise, whereas in HD-affected patients, physical activity appeared to have positive effects on gait, motor function, UHDMRS scale, cognitive function, quality of life, postural stability, total body mass, fatty acid oxidative capacity, and VO2 max. Physical activity seems to be feasible, safe, and effective for HD patients. However, further studies with longer follow-up and larger cohorts of patients will be needed to draw firm conclusions on the positive effects of exercise for HD patients.

Survey on the Most Current Image Processing Methods in Huntington's Disease Diagnostics and Progression Assessment

“…The method works very well in the diagnosis of neoplasms, but from the point of view of HD diagnostics, it is of limited applicability. Histology [60,83] Histology is a technique of microscopic imaging of tissues, which is not relevant for the diagnosis of HD in alive patients due to the way the samples are prepared. The examined tissues are frozen and then cut into very thin layers, which are first photographed.…”

Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route

“…The pathophysiology of HD is specific to the brain and manifests several neuropsychiatric symptoms, including irritability, anxiety, sadness, mental confusion, apathy, and motor dysfunction (Tabrizi et al, 2013;Trovato et al, 2022). The neuronal loss in the striatum and cerebral cortex causes neuronal dysfunction (neurodegeneration) associated with HD (Craufurd et al, 2001).…”